prov:value
| - Our Chief Executive Officer, Harvey J. Berger, our Senior Vice President and Chief Patent Counsel, David Bernstein, our Senior Vice President, Drug Development, John D. Iuliucci, our Senior Vice President and Chief Business Officer, Fritz B. Casselman and other key officers and members of our scientific staff responsible for areas such as clinical development, drug discovery, cell biology and geno
|